| Trade Names: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| Parent Compound: | CAFFEINE |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Apnea | Phase 3 | ClinicalTrials |
| Liver Diseases | Phase 1 | ClinicalTrials |
| Bronchopulmonary Dysplasia | Phase 4 | ClinicalTrials |
| Pain, Postoperative | Early Phase 1 | ClinicalTrials |
| Apnea | Phase 2 | ClinicalTrials |
| Retinopathy of Prematurity | Phase 2 | ClinicalTrials |
| Premature Birth | Phase 3 | ClinicalTrials |
| Ileus | Phase 2 | ClinicalTrials |
| Brain Injuries; Hemorrhage | Phase 4 | ClinicalTrials |
| Apnea; Premature Birth | Phase 3 | ClinicalTrials |
Related Entries
Adverse Reactions
System Organ Classification (SOC)
CONTENTS